Efficacy of a fixed dose combination of irbesartan and atorvastatin (Rovelito(®)) in Korean adults with hypertension and hypercholesterolemia

PURPOSE: Coexistence of hypertension (HTN) and hypercholesterolemia is a major synergistic and modifiable risk factor for cardiovascular disease (CVD). Thus, a fixed-dose combination (FDC) of anti-HTN drugs and statins may be useful for treating CVD. This study evaluated the efficacy of an FDC of ir...

Descripción completa

Detalles Bibliográficos
Autores principales: Ihm, Sang-Hyun, Shin, Jinho, Park, Chang-Gyu, Kim, Cheol-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387596/
https://www.ncbi.nlm.nih.gov/pubmed/30858694
http://dx.doi.org/10.2147/DDDT.S191973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387596/
https://www.ncbi.nlm.nih.gov/pubmed/30858694
http://dx.doi.org/10.2147/DDDT.S191973

Ejemplares similares